Facebook
Twitter
LinkedIn
Home
Research
Materials & Mining
Technology
Healthcare & Life Sciences
Industrials
Consumer Staples
Communication Services
Financials
Utilities & Energy
Insights
Article Insights
Video Insights
About PSR
Contact
Get in Touch
Get in Touch
Home
/
Video Playlist
/
Cyclopharm (ASX:CYC) is expecting FDA approval for Technegas by September 2023!
Cyclopharm (ASX:CYC) is expecting FDA approval for Technegas by September 2023!
November 25, 2025
Check out our interview with CEO James McBrayer (4 April 2023)
Related Videos
View All
AI & Semiconductors Webinar: Nanoveu (ASX:NVU)
September 23, 2026
Marc Kennis
AI & Semiconductors Webinar: Adisyn (ASX:AI1)
September 23, 2026
Marc Kennis
AI & Semiconductors Webinar: BrainChip (ASX:BRN)
September 23, 2026
Marc Kennis
AI & Semiconductors Webinar: Weebit Nano (ASX:WBT)
September 23, 2026
Marc Kennis
Register for the Conference
First Name
*
Last Name
*
Email Address
*
Phone
*
Company Name
*
Job Title
*
Questions or Comments
*
Register Now
